Remove Discovery Remove Litigation Remove Pharmaceuticals
article thumbnail

Legal Turmoil in the Pharmaceutical Industry: AbbVie, Purdue, and Beyond

Complex Discovery

Editor’s Note: In a legal confrontation that could significantly impact the pharmaceutical industry, AbbVie has petitioned the U.S. Circuit Court of Appeals’ February decision that deemed AbbVie’s patent litigation against Perrigo a “sham.” has petitioned the U.S.

article thumbnail

Johnson & Johnson Reaches $700 Million Settlement Over Talcum Powder Litigation

Complex Discovery

states over talcum powder litigation marks a pivotal moment in consumer protection and corporate accountability. This case highlights critical issues surrounding product safety, transparency, and the ethical responsibilities of corporations, especially within the pharmaceutical industry. for Mass., $6m 6m for N.H., nearly $7m for R.I.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Eleventh Circuit Upholds Sanctions in Energy Drink Dispute for Failure to Provide Computation of Damages

IP Watchdog

Court of Appeals for the Eleventh Circuit affirmed a district court’s ruling against Vital Pharmaceuticals, Inc. VPX) in the form of sanctions for violating its discovery obligations in a trade dress dispute with Monster Energy Company. On Wednesday, August 3, the U.S.

article thumbnail

Addressing Critical Information Governance Challenges from Departing Employees

Next Generation E-Discovery Law & Tech Blog

This poses major information governance challenges, as companies must decide how to manage litigation holds and retain essential data assets. Leveraging X1’s unique and patented in-place indexing technology, data extraction becomes highly targeted, allowing for efficient responses to litigation holds.

article thumbnail

Riding the M&A Wave: What February’s 230 HSR Transactions Reveal About Economic Trends and Risk Management

Complex Discovery

Healthcare and Pharma Consolidation: With regulatory shifts and technological advancements in biotech, pharmaceutical mergers are increasing, driven by both innovation and cost-saving incentives. Poor governance can also lead to litigation risks if sensitive data is mismanaged. The solution?

article thumbnail

eDiscovery Vendor Voices in October 2024: The Rise of AI and Strategic Leadership Moves

Complex Discovery

Such capabilities are essential for addressing the challenges of cross-border litigation and vast data volumes, ensuring higher efficiency and accuracy. UnitedLex appointed Renee Meisel as its new CEO, signaling a shift toward bolstered leadership aimed at driving innovation across its litigation and compliance offerings.